| 000 | 01510 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250518030448.0 | ||
| 264 | 0 | _c20201005 | |
| 008 | 202010s 0 0 eng d | ||
| 022 | _a2045-2322 | ||
| 024 | 7 |
_a10.1038/s41598-019-41106-3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPatera, Foteini | |
| 245 | 0 | 0 |
_aRenal expression of JAK2 is high in polycystic kidney disease and its inhibition reduces cystogenesis. _h[electronic resource] |
| 260 |
_bScientific reports _c03 2019 |
||
| 300 |
_a4491 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 | _aCell Proliferation |
| 650 | 0 | 4 |
_aCurcumin _xpharmacology |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aEpithelial Cells _xcytology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aJanus Kinase 2 _xmetabolism |
| 650 | 0 | 4 |
_aKidney _xmetabolism |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aPhosphorylation _xdrug effects |
| 650 | 0 | 4 |
_aPiperidines _xpharmacology |
| 650 | 0 | 4 |
_aPolycystic Kidney, Autosomal Dominant _xgenetics |
| 650 | 0 | 4 |
_aPyrimidines _xpharmacology |
| 650 | 0 | 4 |
_aPyrroles _xpharmacology |
| 650 | 0 | 4 |
_aTRPP Cation Channels _xgenetics |
| 650 | 0 | 4 |
_aUp-Regulation _xdrug effects |
| 700 | 1 | _aCudzich-Madry, Alex | |
| 700 | 1 | _aHuang, Zhi | |
| 700 | 1 | _aFragiadaki, Maria | |
| 773 | 0 |
_tScientific reports _gvol. 9 _gno. 1 _gp. 4491 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/s41598-019-41106-3 _zAvailable from publisher's website |
| 999 |
_c29478697 _d29478697 |
||